CN100396316C

CN100396316C - Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny

Info

Publication number: CN100396316C
Application number: CNB2006100433821A
Authority: CN
Inventors: 于胜颐
Original assignee: Individual
Current assignee: Individual
Priority date: 2006-03-21
Filing date: 2006-03-21
Publication date: 2008-06-25
Anticipated expiration: 2026-03-21
Also published as: CN1857636A

Abstract

The present invention discloses a Chinese medicine for treating intervertebral disk hernia and hyperostosis, namely a meridian promoting capsule. The present invention comprises raw material compositions of effective ingredients and weight mixture ratios thereof as follows: one to two parts of notopterygium roots, one to two parts of pubescent angelica roots, two to three parts of clematis roots, two to three parts of acanthopanax bark, two to three parts of pueraria roots, two to three parts of sichuan aconite roots, two to three parts of draconis resin, one to two parts of mastic, one to two parts of myrrh, two to three parts of safflowers, two to three parts of rhizoma drynariae, two to three parts of charred CORTEX EUCOMMIAE, two to three parts of long-noded pit vipers, one to two parts of earthworms, one to two parts of ground beetles, one to two parts of scorpions and one to two parts of centipedes. The medicine of the present invention is combined with the pelvic traction and hand restitution for application so as to obtain good and quick treating effect.

Description

A kind of Chinese medicinal capsule for the treatment of intervertebral disc prolapse and bone matrix hyperplasia

Technical field

The present invention relates to a kind of is the pharmaceutical composition of raw material with the Chinese herbal medicine, specifically relates to a kind of Chinese medicinal capsule for the treatment of intervertebral disk hernia and bone matrix hyperplasia.

Background technology

Hyperosteogeny, intervertebral disc prolapse are a kind of commonly encountered diseases, frequently-occurring diseases that has a strong impact on work capacity, and in China the trend that increases are year by year arranged.The arthromyodynia category of the primary disease ownership traditional Chinese medical science.Chinese medicine thinks, the wind-cold damp pathogen invasion and attack, and acute and chronic trauma causes meridians impatency, QI-blood circulation smooth and cause a disease, so forefathers have " numbness person closes also ", the saying of " bitterly then obstructed, general rule is not bitterly ".The primary disease primary symptom is a lumbago and skelalgia, and it causes the machine-processed more complicated of lumbago and skelalgia, but mainly is mechanical pressure and two aspects of chemical stimulation.Mechanical pressure occurs formerly, after chemical stimulation occurs in.Aseptic inflammations such as the compressing of proliferation stimulates can cause nerve root hyperemia, ooze out, edema, degeneration, adhesion are secreted multiple algogenic substances such as Kallidin I then.Present treatment for primary disease, except that operation, major part is carried out expectant treatment, wherein pelvic traction and manual reduction are the most frequently used basic skills, though said method can alleviate mechanical pressure effectively, but it can not eliminate chemical stimulation effectively, remove the swelling and the congestion pain in partial wind-cold damp pathogen and affected part, and the course of treatment is longer.Existing oral drugs, Western medicine such as chlorzoxazone, ibuprofen, indometacin etc. mostly to unsting, can not effect a radical cure this disease, and patient is easy to generate drug dependence, take toxic side effect for a long time.And Chinese patent medicine such as bony spur tablet, SHENJIN DAN etc., though have no side effect, therapeutic effect is very unobvious." Chinese medicine composition of treatment intervertebral disc bone matrix hyperplasia " of external Chinese medicine such as patent No. ZL03142018.4 and " a kind of plaster for the treatment of intervertebral disc prolapse " of patent No. CN200310105386.4 etc., though effect is better, curative effect is long, the medication inconvenience.

Summary of the invention

Purpose of the present invention is exactly that a kind of oral Chinese medicine-capsule that stimulates the menstrual flow that is used with pelvic traction and manual reduction traction to treat will be provided, thereby can more effective, more promptly treat intervertebral disc prolapse and bone matrix hyperplasia.

For achieving the above object, the present invention's Chinese medicine-capsular characteristics of stimulating the menstrual flow for the treatment of intervertebral disc prolapse and bone matrix hyperplasia raw material of being to form this pharmaceutically active ingredient constitutes and weight proportion is: Rhizoma Et Radix Notopterygii 1-2 part, Radix Angelicae Pubescentis 1-2 part, Radix Clematidis 2-3 part, Cortex Acanthopancis 2-3 part, Radix Puerariae 2-3 part, Radix Aconiti 2-3 part, Sanguis Draxonis 1-2 part, Olibanum 1-2 part, Myrrha 1-2 part, Flos Carthami 2-3 part, Rhizoma Drynariae 2-3 part, charred Cortex Eucommiae 2-3 part, Agkistrodon 2-3 part, Pheretima 1-2 part, Eupolyphaga Seu Steleophaga 1-2 part, Scorpio 1-2 part, Scolopendra 1-2 part.

The raw material optimum weight proportioning of forming this pharmaceutically active ingredient is: 1 part of Rhizoma Et Radix Notopterygii, 1 part of Radix Angelicae Pubescentis, 2 parts of Radix Clematidis, 2 parts of Cortex Acanthopanciss, 2 parts of Radix Puerariaes, 2 parts of Radix Aconitis, 1.5 parts of Sanguis Draxonis, 1.5 parts of Olibanums, 1.5 parts of Myrrhas, 2 parts on Flos Carthami, 2 parts of Rhizoma Drynariae, 2 parts of charred Cortex Eucommiaes, 2 parts of Agkistrodons, 2 parts of Pheretimas, 2 parts of Eupolyphaga Seu Steleophagas, 1 part of Scorpio, 1 part of Scolopendra.

Chinese medicine-capsular the preparation method of stimulating the menstrual flow that the present invention treats intervertebral disc prolapse and bone matrix hyperplasia is: take by weighing the raw material of Chinese medicine of respectively distinguishing the flavor of by weight ratio, 120 mesh sieves are dried, pulverized to mix homogeneously, ozone sterilization 20 minutes, medicated powder incapsulated get final product every powder charge 0.45 gram.

The medicine of the present invention capsule that stimulates the menstrual flow is once taken 4, and twice, 30 day on the one is a course of treatment, and it is better to make the guiding drug effect with warm yellow wine.Capsule of the present invention has dispelling cold by warming the meridian, dispels damp, the effect of activating blood circulation to dissipate blood stasis, promotion local blood circulation, is used for treatment intervertebral disc prolapse and bone matrix hyperplasia, lays particular emphasis on and removes its chemical stimulation, promotes the metabolism of algogenic substance to get rid of.Through clinical verification for many years, medicine of the present invention combines application with pelvic traction and manual reduction traction to treat, can obtain better, curative effect more efficiently, and its cure rate can reach 60%, accounts for 80% more than the produce effects.Medicine of the present invention is pure Chinese medicinal preparation, and is without any side effects, and taking convenience is not taken for a long time and can be produced drug dependence, and raw material is easy to get, and drug cost is low, has alleviated the financial burden of patient treatment.

The specific embodiment

Embodiment one:

Forming this invention medicine-capsule raw materials of effective components of stimulating the menstrual flow formation and weight proportion thereof is: 1 part of Rhizoma Et Radix Notopterygii, 2 parts of Radix Angelicae Pubescentiss, 2 parts of Radix Clematidis, 3 parts of Cortex Acanthopanciss, 2 parts of Radix Puerariaes, 3 parts of Radix Aconitis, 1 part of Sanguis Draxonis, 2 parts of Olibanums, 1 part of Myrrha, 3 parts on Flos Carthami, 2 parts of Rhizoma Drynariae, 3 parts of charred Cortex Eucommiaes, 2 parts of Agkistrodons, 2 parts of Pheretimas, 1 part of Eupolyphaga Seu Steleophaga, 2 parts of Scorpios, 1 part of Scolopendra.

Embodiment two:

Forming this invention medicine-capsule raw materials of effective components of stimulating the menstrual flow formation and weight proportion thereof is: 2 parts of Rhizoma Et Radix Notopterygiis, 1 part of Radix Angelicae Pubescentis, 3 parts of Radix Clematidis, 2 parts of Cortex Acanthopanciss, 3 parts of Radix Puerariaes, 2 parts of Radix Aconitis, 2 parts of Sanguis Draxonis, 1 part of Olibanum, 2 parts of Myrrhas, 2 parts on Flos Carthami, 3 parts of Rhizoma Drynariae, 2 parts of charred Cortex Eucommiaes, 3 parts of Agkistrodons, 1 part of Pheretima, 2 parts of Eupolyphaga Seu Steleophagas, 1 part of Scorpio, 2 parts of Scolopendras.

Embodiment three

Forming this invention medicine-capsule raw materials of effective components of stimulating the menstrual flow formation and weight proportion thereof is: 1 part of Rhizoma Et Radix Notopterygii, 1 part of Radix Angelicae Pubescentis, 2 parts of Radix Clematidis, 2 parts of Cortex Acanthopanciss, 2 parts of Radix Puerariaes, 2 parts of Radix Aconitis, 1.5 parts of Sanguis Draxonis, 1.5 parts of Olibanums, 1.5 parts of Myrrhas, 2 parts on Flos Carthami, 2 parts of Rhizoma Drynariae, 2 parts of charred Cortex Eucommiaes, 2 parts of Agkistrodons, 2 parts of Pheretimas, 2 parts of Eupolyphaga Seu Steleophagas, 1 part of Scorpio, 1 part of Scolopendra.

Embodiment three is a most preferred embodiment.The preparation method of embodiment as previously described.

Claims

1. a Chinese medicinal capsule for the treatment of intervertebral disc prolapse and bone matrix hyperplasia is characterized in that raw material formation and the weight proportion thereof of forming this pharmaceutically active ingredient are: Rhizoma Et Radix Notopterygii 1-2 part, Radix Angelicae Pubescentis 1-2 part, Radix Clematidis 2-3 part, Cortex Acanthopancis 2-3 part, Radix Puerariae 2-3 part, Radix Aconiti 2-3 part, Sanguis Draxonis 1-2 part, Olibanum 1-2 part, Myrrha 1-2 part, Flos Carthami 2-3 part, Rhizoma Drynariae 2-3 part, charred Cortex Eucommiae 2-3 part, Agkistrodon 2-3 part, Pheretima 1-2 part, Eupolyphaga Seu Steleophaga 1-2 part, Scorpio 1-2 part, Scolopendra 1-2 part.

2. the Chinese medicinal capsule of treatment intervertebral disc prolapse according to claim 1 and bone matrix hyperplasia is characterized in that raw material formation and the weight proportion thereof of forming this pharmaceutically active ingredient are: 1 part of Rhizoma Et Radix Notopterygii, 1 part of Radix Angelicae Pubescentis, 2 parts of Radix Clematidis, 2 parts of Cortex Acanthopanciss, 2 parts of Radix Puerariaes, 2 parts of Radix Aconitis, 1.5 parts of Sanguis Draxonis, 1.5 parts of Olibanums, 1.5 parts of Myrrhas, 2 parts on Flos Carthami, 2 parts of Rhizoma Drynariae, 2 parts of charred Cortex Eucommiaes, 2 parts of Agkistrodons, 2 parts of Pheretimas, 2 parts of Eupolyphaga Seu Steleophagas, 1 part of Scorpio, 1 part of Scolopendra.